Clinical efficacy of GLP-1 receptor agonists in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials
{{output}}
Background: Parkinson's disease (PD) is a degenerative disorder of the nervous system. The neurobiological implications of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in modifying PD risk profile remain incompletely cha... ...
